Cargando…

The toxin biliatresone causes mouse extrahepatic cholangiocyte damage and fibrosis through decreased glutathione and SOX17

Biliary atresia, the most common indication for pediatric liver transplantation, is a fibrotic disease of unknown etiology affecting the extrahepatic bile ducts of newborns. The recently described toxin biliatresone causes lumen obstruction in mouse cholangiocyte spheroids and represents a new model...

Descripción completa

Detalles Bibliográficos
Autores principales: Waisbourd‐Zinman, Orith, Koh, Hong, Tsai, Shannon, Lavrut, Pierre‐Marie, Dang, Christine, Zhao, Xiao, Pack, Michael, Cave, Jeff, Hawes, Mark, Koo, Kyung A., Porter, John R., Wells, Rebecca G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4992464/
https://www.ncbi.nlm.nih.gov/pubmed/27081925
http://dx.doi.org/10.1002/hep.28599
_version_ 1782449013870559232
author Waisbourd‐Zinman, Orith
Koh, Hong
Tsai, Shannon
Lavrut, Pierre‐Marie
Dang, Christine
Zhao, Xiao
Pack, Michael
Cave, Jeff
Hawes, Mark
Koo, Kyung A.
Porter, John R.
Wells, Rebecca G.
author_facet Waisbourd‐Zinman, Orith
Koh, Hong
Tsai, Shannon
Lavrut, Pierre‐Marie
Dang, Christine
Zhao, Xiao
Pack, Michael
Cave, Jeff
Hawes, Mark
Koo, Kyung A.
Porter, John R.
Wells, Rebecca G.
author_sort Waisbourd‐Zinman, Orith
collection PubMed
description Biliary atresia, the most common indication for pediatric liver transplantation, is a fibrotic disease of unknown etiology affecting the extrahepatic bile ducts of newborns. The recently described toxin biliatresone causes lumen obstruction in mouse cholangiocyte spheroids and represents a new model of biliary atresia. The goal of this study was to determine the cellular changes caused by biliatresone in mammalian cells that ultimately lead to biliary atresia and extrahepatic fibrosis. We treated mouse cholangiocytes in three‐dimensional (3D) spheroid culture and neonatal extrahepatic duct explants with biliatresone and compounds that regulate glutathione (GSH). We examined the effects of biliatresone on SOX17 levels and determined the effects of Sox17 knockdown on cholangiocytes in 3D culture. We found that biliatresone caused disruption of cholangiocyte apical polarity and loss of monolayer integrity. Spheroids treated with biliatresone had increased permeability as shown by rhodamine efflux within 5 hours compared with untreated spheroids, which retained rhodamine for longer than 12 hours. Neonatal bile duct explants treated with the toxin showed lumen obstruction with increased subepithelial staining for α‐smooth muscle actin and collagen, consistent with fibrosis. Biliatresone caused a rapid and transient decrease in GSH, which was both necessary and sufficient to mediate its effects in cholangiocyte spheroid and bile duct explant systems. It also caused a significant decrease in cholangiocyte levels of SOX17, and Sox17 knockdown in cholangiocyte spheroids mimicked the effects of biliatresone. Conclusion: Biliatresone decreases GSH and SOX17 in mouse cholangiocytes. In 3D cell systems, this leads to cholangiocyte monolayer damage and increased permeability; in extrahepatic bile duct explants, it leads to disruption of the extrahepatic biliary tree and subepithelial fibrosis. This mechanism may be important in understanding human biliary atresia. (Hepatology 2016;64:880‐893)
format Online
Article
Text
id pubmed-4992464
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-49924642017-09-01 The toxin biliatresone causes mouse extrahepatic cholangiocyte damage and fibrosis through decreased glutathione and SOX17 Waisbourd‐Zinman, Orith Koh, Hong Tsai, Shannon Lavrut, Pierre‐Marie Dang, Christine Zhao, Xiao Pack, Michael Cave, Jeff Hawes, Mark Koo, Kyung A. Porter, John R. Wells, Rebecca G. Hepatology Autoimmune, Cholestatic and Biliary Disease Biliary atresia, the most common indication for pediatric liver transplantation, is a fibrotic disease of unknown etiology affecting the extrahepatic bile ducts of newborns. The recently described toxin biliatresone causes lumen obstruction in mouse cholangiocyte spheroids and represents a new model of biliary atresia. The goal of this study was to determine the cellular changes caused by biliatresone in mammalian cells that ultimately lead to biliary atresia and extrahepatic fibrosis. We treated mouse cholangiocytes in three‐dimensional (3D) spheroid culture and neonatal extrahepatic duct explants with biliatresone and compounds that regulate glutathione (GSH). We examined the effects of biliatresone on SOX17 levels and determined the effects of Sox17 knockdown on cholangiocytes in 3D culture. We found that biliatresone caused disruption of cholangiocyte apical polarity and loss of monolayer integrity. Spheroids treated with biliatresone had increased permeability as shown by rhodamine efflux within 5 hours compared with untreated spheroids, which retained rhodamine for longer than 12 hours. Neonatal bile duct explants treated with the toxin showed lumen obstruction with increased subepithelial staining for α‐smooth muscle actin and collagen, consistent with fibrosis. Biliatresone caused a rapid and transient decrease in GSH, which was both necessary and sufficient to mediate its effects in cholangiocyte spheroid and bile duct explant systems. It also caused a significant decrease in cholangiocyte levels of SOX17, and Sox17 knockdown in cholangiocyte spheroids mimicked the effects of biliatresone. Conclusion: Biliatresone decreases GSH and SOX17 in mouse cholangiocytes. In 3D cell systems, this leads to cholangiocyte monolayer damage and increased permeability; in extrahepatic bile duct explants, it leads to disruption of the extrahepatic biliary tree and subepithelial fibrosis. This mechanism may be important in understanding human biliary atresia. (Hepatology 2016;64:880‐893) John Wiley and Sons Inc. 2016-05-20 2016-09 /pmc/articles/PMC4992464/ /pubmed/27081925 http://dx.doi.org/10.1002/hep.28599 Text en © 2016 The Authors. Hepatology published by Wiley Periodicals, Inc., on behalf of the American Association for the Study of Liver Diseases. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Autoimmune, Cholestatic and Biliary Disease
Waisbourd‐Zinman, Orith
Koh, Hong
Tsai, Shannon
Lavrut, Pierre‐Marie
Dang, Christine
Zhao, Xiao
Pack, Michael
Cave, Jeff
Hawes, Mark
Koo, Kyung A.
Porter, John R.
Wells, Rebecca G.
The toxin biliatresone causes mouse extrahepatic cholangiocyte damage and fibrosis through decreased glutathione and SOX17
title The toxin biliatresone causes mouse extrahepatic cholangiocyte damage and fibrosis through decreased glutathione and SOX17
title_full The toxin biliatresone causes mouse extrahepatic cholangiocyte damage and fibrosis through decreased glutathione and SOX17
title_fullStr The toxin biliatresone causes mouse extrahepatic cholangiocyte damage and fibrosis through decreased glutathione and SOX17
title_full_unstemmed The toxin biliatresone causes mouse extrahepatic cholangiocyte damage and fibrosis through decreased glutathione and SOX17
title_short The toxin biliatresone causes mouse extrahepatic cholangiocyte damage and fibrosis through decreased glutathione and SOX17
title_sort toxin biliatresone causes mouse extrahepatic cholangiocyte damage and fibrosis through decreased glutathione and sox17
topic Autoimmune, Cholestatic and Biliary Disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4992464/
https://www.ncbi.nlm.nih.gov/pubmed/27081925
http://dx.doi.org/10.1002/hep.28599
work_keys_str_mv AT waisbourdzinmanorith thetoxinbiliatresonecausesmouseextrahepaticcholangiocytedamageandfibrosisthroughdecreasedglutathioneandsox17
AT kohhong thetoxinbiliatresonecausesmouseextrahepaticcholangiocytedamageandfibrosisthroughdecreasedglutathioneandsox17
AT tsaishannon thetoxinbiliatresonecausesmouseextrahepaticcholangiocytedamageandfibrosisthroughdecreasedglutathioneandsox17
AT lavrutpierremarie thetoxinbiliatresonecausesmouseextrahepaticcholangiocytedamageandfibrosisthroughdecreasedglutathioneandsox17
AT dangchristine thetoxinbiliatresonecausesmouseextrahepaticcholangiocytedamageandfibrosisthroughdecreasedglutathioneandsox17
AT zhaoxiao thetoxinbiliatresonecausesmouseextrahepaticcholangiocytedamageandfibrosisthroughdecreasedglutathioneandsox17
AT packmichael thetoxinbiliatresonecausesmouseextrahepaticcholangiocytedamageandfibrosisthroughdecreasedglutathioneandsox17
AT cavejeff thetoxinbiliatresonecausesmouseextrahepaticcholangiocytedamageandfibrosisthroughdecreasedglutathioneandsox17
AT hawesmark thetoxinbiliatresonecausesmouseextrahepaticcholangiocytedamageandfibrosisthroughdecreasedglutathioneandsox17
AT kookyunga thetoxinbiliatresonecausesmouseextrahepaticcholangiocytedamageandfibrosisthroughdecreasedglutathioneandsox17
AT porterjohnr thetoxinbiliatresonecausesmouseextrahepaticcholangiocytedamageandfibrosisthroughdecreasedglutathioneandsox17
AT wellsrebeccag thetoxinbiliatresonecausesmouseextrahepaticcholangiocytedamageandfibrosisthroughdecreasedglutathioneandsox17
AT waisbourdzinmanorith toxinbiliatresonecausesmouseextrahepaticcholangiocytedamageandfibrosisthroughdecreasedglutathioneandsox17
AT kohhong toxinbiliatresonecausesmouseextrahepaticcholangiocytedamageandfibrosisthroughdecreasedglutathioneandsox17
AT tsaishannon toxinbiliatresonecausesmouseextrahepaticcholangiocytedamageandfibrosisthroughdecreasedglutathioneandsox17
AT lavrutpierremarie toxinbiliatresonecausesmouseextrahepaticcholangiocytedamageandfibrosisthroughdecreasedglutathioneandsox17
AT dangchristine toxinbiliatresonecausesmouseextrahepaticcholangiocytedamageandfibrosisthroughdecreasedglutathioneandsox17
AT zhaoxiao toxinbiliatresonecausesmouseextrahepaticcholangiocytedamageandfibrosisthroughdecreasedglutathioneandsox17
AT packmichael toxinbiliatresonecausesmouseextrahepaticcholangiocytedamageandfibrosisthroughdecreasedglutathioneandsox17
AT cavejeff toxinbiliatresonecausesmouseextrahepaticcholangiocytedamageandfibrosisthroughdecreasedglutathioneandsox17
AT hawesmark toxinbiliatresonecausesmouseextrahepaticcholangiocytedamageandfibrosisthroughdecreasedglutathioneandsox17
AT kookyunga toxinbiliatresonecausesmouseextrahepaticcholangiocytedamageandfibrosisthroughdecreasedglutathioneandsox17
AT porterjohnr toxinbiliatresonecausesmouseextrahepaticcholangiocytedamageandfibrosisthroughdecreasedglutathioneandsox17
AT wellsrebeccag toxinbiliatresonecausesmouseextrahepaticcholangiocytedamageandfibrosisthroughdecreasedglutathioneandsox17